WO2003088912A2 - Removable anchored lung volume reduction devices and methods - Google Patents

Removable anchored lung volume reduction devices and methods Download PDF

Info

Publication number
WO2003088912A2
WO2003088912A2 PCT/US2003/011974 US0311974W WO03088912A2 WO 2003088912 A2 WO2003088912 A2 WO 2003088912A2 US 0311974 W US0311974 W US 0311974W WO 03088912 A2 WO03088912 A2 WO 03088912A2
Authority
WO
WIPO (PCT)
Prior art keywords
air passageway
obstructing member
anchoring device
intra
obstructing
Prior art date
Application number
PCT/US2003/011974
Other languages
French (fr)
Other versions
WO2003088912A3 (en
Inventor
Lauri J. Devore
Original Assignee
Spiration, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spiration, Inc. filed Critical Spiration, Inc.
Priority to JP2003585665A priority Critical patent/JP2005523076A/en
Priority to CA002484086A priority patent/CA2484086A1/en
Priority to EP03721749A priority patent/EP1494657A4/en
Priority to AU2003225044A priority patent/AU2003225044B2/en
Publication of WO2003088912A2 publication Critical patent/WO2003088912A2/en
Publication of WO2003088912A3 publication Critical patent/WO2003088912A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12104Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in an air passage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12159Solid plugs; being solid before insertion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/04Tracheal tubes
    • A61M16/0402Special features for tracheal tubes not otherwise provided for
    • A61M16/0404Special features for tracheal tubes not otherwise provided for with means for selective or partial lung respiration
    • A61M16/0406Special features for tracheal tubes not otherwise provided for with means for selective or partial lung respiration implanted flow modifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22051Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation
    • A61B2017/22065Functions of balloons
    • A61B2017/22067Blocking; Occlusion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/24Surgical instruments, devices or methods, e.g. tourniquets for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers
    • A61B2017/242Surgical instruments, devices or methods, e.g. tourniquets for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers for bronchial passages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/03Automatic limiting or abutting means, e.g. for safety
    • A61B2090/033Abutting means, stops, e.g. abutting on tissue or skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418Scaffolds therefor, e.g. support stents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/04Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2002/043Bronchi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/848Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents having means for fixation to the vessel wall, e.g. barbs
    • A61F2002/8483Barbs

Definitions

  • the present invention is generally directed to a removable anchored device, system, and method for treating Chronic Obstructive Pulmonary Disease (COPD) .
  • COPD Chronic Obstructive Pulmonary Disease
  • the present invention is more particularly directed to providing an anchored intra-bronchial obstruction that may be removable.
  • COPD has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structural abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia, and smooth muscle hypertrophy in terminal bronchioles .
  • a promising new therapy includes non-surgical apparatus and procedures for lung volume reduction by permanently obstructing the air passageway that communicates with the portion of the lung to be collapsed.
  • the therapy includes placing an obstruction in the air passageway that prevents inhaled air from flowing into the portion of the lung to be collapsed. This provides lung volume reduction with concomitant improved pulmonary function without the need for surgery.
  • the effectiveness of obstructions may be enhanced if it is anchored in place.
  • the effectiveness may also be enhanced if the obstruction is removable.
  • the present invention provides an intra-bronchial device for placement in an air passageway of a patient to collapse a lung portion associated with the air passageway.
  • the device includes an obstructing member that prevents air from being inhaled into the lung portion to collapse the lung portion, and an anchoring device that anchors the obstructing member in the air passageway by engaging the obstructing member and the air passageway wall.
  • the anchoring device may frictionally engage the obstructing member.
  • the engagement provided by the anchoring device may be releasable for removal of the obstructing member.
  • the anchoring device may comprise a material having a memory of an original undistorted shape, and a resiliency to return the material from a distorted shape to the original undistorted shape.
  • the anchoring device may be balloon expandable from a first shape to a second shape that engages the obstructing member and the air passageway.
  • the obstructing member may be a one-way valve.
  • the device includes an obstructing member that prevents air from being inhaled into the lung portion to collapse the lung portion, and an anchoring device having a projection that anchors the obstructing member in the air passageway by piercingly engaging the obstructing member and the air passageway wall.
  • the engagement provided by the anchoring device may be releasable for removal of the obstructing member.
  • the anchoring device may comprise a material having a memory of an original undistorted shape, and a resiliency to return the material from a distorted shape to the original undistorted shape.
  • the anchoring device may be balloon expandable from a compressed shape to a deployed shape that engages the obstructing member and the air passageway wall .
  • the anchoring device may be configured to urge engagement with the air passageway wall.
  • the projection may be releasable from the air passageway wall for removal of the anchoring device.
  • the projection may include a stop dimensioned to limit the piercing. At least a portion of the anchoring device may be collapsible for placement in the air passageway.
  • the anchoring device may collapse centrally.
  • the anchoring device may include a projection that collapses centrally.
  • the anchoring device may be configured to move from a first position to a second position to anchor the obstructing member in the air passageway.
  • the anchoring device may be configured to move from a first position to a second position to anchor the obstructing member in the air passageway, and to move from the second position to the first position to disengage the obstructing member for removal from the air passageway.
  • the obstructing member may be a one-way valve .
  • the method includes the step of providing an intra- bronchial device having an obstructing member which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and an anchoring device that anchors the obstructing member in the air passageway by engaging the obstructing member and the wall of the air passageway.
  • the method also includes the steps of placing the obstructing member in the air passageway, placing the anchoring device in the air passageway, and deploying the anchoring device.
  • the anchoring device may include a projection that piercingly engages the obstructing member and the air passageway wall.
  • the anchoring device may be releasable for removal of the intra-bronchial device.
  • the obstructing member may form a one-way valve. At least a portion of the anchoring device may be collapsible.
  • a further embodiment provides a method of reducing the size of a lung by collapsing a portion of the lung.
  • the method includes the step of providing an intra-bronchial device having an obstructing member which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and an anchoring device that anchors the obstructing member in the air passageway by engaging the obstructing member and the wall of the air passageway.
  • the method also includes the steps of placing the obstructing member in the air passageway, placing the anchoring device in the air passageway, deploying the anchoring device, removing the anchoring device, and removing the obstructing member.
  • the anchoring device may include a projection that piercingly engages the obstructing member and the air passageway wall.
  • the anchoring device may include a projection that piercingly engages the obstructing member and the air passageway wall.
  • the projection may be releasable from the air passageway wall for removal of the anchoring device, and the step of removing the anchoring device includes releasing the projection.
  • the obstructing member may form a one-way valve. A portion of the anchoring device may be collapsible.
  • Yet another embodiment provides an air passageway obstructing device having obstructing means for obstructing air flow within the air passageway, and anchoring means for anchoring the obstructing means within an air passageway by engaging the obstructing means and the air passageway, and the anchoring means being further releasable for removal of the obstructing means.
  • Figure 2 is a sectional view similar to FIG. 1, but illustrating a respiratory system suffering from COPD, and the execution of a first step in treating the COPD condition by reducing the size of a lung portion in accordance with the present invention
  • Figure 3 is perspective view, partially in section, and to an enlarged scale, illustrating an intermediate step in the treatment;
  • Figure 4 illustrates an anchoring device being delivered through a catheter for placement in proximity to the obstructing member and deployment, in accordance with the invention;
  • Figure 5 illustrates the obstructing device anchored in place within an air passageway by the anchoring device, in accordance with the invention
  • Figure 6 is a perspective view of an anchoring device, as the device would appear when fully deployed in an air passageway, in accordance with the present invention
  • Figure 7 is a perspective view of an intra-bronchial device comprising an obstructing member and the anchoring device of FIG. 6 anchored in an air passageway in accordance with the present invention
  • Figure 8 is a perspective view of an annular anchoring device as the device would appear when fully deployed in an air passageway, in accordance with the present invention
  • Figure 9 is a perspective view of an intra-bronchial device comprising an obstructing member and the annular anchoring device of FIG. 8 anchored in an air passageway, in accordance with the present invention.
  • Figure 10 is a plan view of the annular anchoring device of FIG. 8 engaged in the proximal end of an obstructive device, in accordance with the present invention.
  • proximal means nearest the trachea
  • distal means nearest the bronchioles.
  • an anchored intra-bronchial device for placement in an air passageway of a patient to collapse or reduce ventilation to a lung portion associated with the air passageway.
  • An obstructing member is first placed in the air passageway, and then an anchoring device is deployed which anchors the obstructing member in place.
  • a further aspect of the invention provides removability of the intra-bronchial device by releasing the anchoring device for removal of the obstructing member.
  • FIG. 1 is a sectional view of a healthy respiratory system.
  • the respiratory system 20 resides within the thorax 22 that occupies a space defined by the chest wall 24 and the diaphragm 26.
  • the respiratory system 20 includes the trachea 28, the left mainstem bronchus 30, the right mainstem bronchus 32, the bronchial branches 34, 36, 38, 40, and 42 and sub-branches 44, 46, 48, and 50.
  • the respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56,
  • Each bronchial branch and sub-branch communicates with a respective different portion of a lung lobe, either the entire lung lobe, a segment, or a portion thereof.
  • air passageway is meant to denote either bronchi or bronchioles, and typically means a bronchus branch or sub-branch that communicates with a corresponding individual lung lobe, segment, or lung lobe tissue portion to provide inhaled air thereto or conduct exhaled air therefrom.
  • Characteristic of a healthy respiratory system is the arched or inwardly arcuate diaphragm 26. As the individual inhales, the diaphragm 26 straightens to increase the volume of the thorax 22.
  • FIG. 2 illustrates a respiratory system suffering from COPD.
  • the lung lobes 52, 54, 56, 58, and 60 are enlarged and that the diaphragm 26 is not arched but substantially straight.
  • this individual is incapable of breathing normally by moving diaphragm 28.
  • this individual in order to create the negative pressure in thorax 22 required for breathing, this individual must move the chest wall outwardly to increase the volume of the thorax. This results in inefficient breathing causing these individuals to breathe rapidly with shallow breaths.
  • bronchial sub-branch obstructing devices are generally employed for treating the apex 66 of the right, upper lung lobe 56.
  • the present invention may be applied to any lung portion without departing from the present invention.
  • the present invention may be used with any type of obstructing member to provide an anchored obstructing device, which may be removed.
  • FIG. 2 also illustrates a step in COPD treatment using an obstructing member using a bronchoscope or catheter.
  • Catheter 70 may be used alone to perform the insertion, may be extended from a bronchoscope, or used in conjunction with a bronchoscope. For purposes of this description, the insertion will be described with reference to only the catheter 70.
  • Treatment is initiated by feeding a conduit or catheter 70 down the trachea 28, into the right mainstem bronchus 32, into the bronchial branch 42 and into and terminating within the sub-branch 50.
  • the sub-branch 50 is the air passageway that communicates with the lung portion 66 to be treated, and is also referred to herein as air passageway 50.
  • the catheter 70 is preferably formed of flexible material such as polyethylene.
  • the catheter 70 is preferably preformed with a bend 72 (or capable of bending) to assist the feeding of the catheter from the right mainstem bronchus 32 into the bronchial branch 42, or could be deformed to conform to different curvature and angles of a bronchial tree.
  • a bend 72 or capable of bending
  • FIG. 3 illustrates a further step in a method for inserting an obstructing member 90 in a bronchial sub-branch using a catheter or a bronchoscope.
  • Catheter 70 may include an optional inflatable sealing member 74 for use with a vacuum to collapse lung portion 66 prior to insertion of obstructing member 90.
  • the obstructing member 90 may be formed of resilient or collapsible material to enable the obstructing member 90 to be fed through the conduit 70 in a collapsed state.
  • a stylet or biopsy forceps hereafter referred to as a stylet 92, is used to push the obstructing member 90 to the end 77 of the catheter 70 for inserting the obstructing member 90 within the air passageway 50 adjacent to the lung portion 66 to be permanently collapsed.
  • Optional sealing member 74 is withdrawn after obstructing member 90 is inserted.
  • Obstructing one of the collateral air passageways may reduce the volume of the lung portion associated with the air passageway, but not completely collapse the lung portion as that term may be generally understood.
  • the meaning of "collapse" includes both a complete collapse of a lung portion and a partial collapse of a lung portion.
  • the obstructing member precludes inhaled air from entering the lung portion to be collapsed.
  • the obstructing member takes the form of a one-way valve.
  • the member further allows air within the lung portion to be exhaled. This results in more rapid collapse of the lung portion.
  • anchoring obstructing members that preclude both inhaled and exhaled airflow are contemplated as within the scope of the invention.
  • FIG. 4 illustrates an anchoring device being delivered through a catheter for placement in proximity to the obstructing member and deployment, in accordance with the invention.
  • a previously compressed anchoring device 100 is pushed by stylet 92 to the end 77 of the catheter 70 for placement in proximity to the obstructing member 90.
  • Anchoring device 100 is pushed from the catheter 70 into place and into proximity with the obstructing member 90, the resiliency of the anchor projections moves them peripherally.
  • Anchoring device 100 is deployed by further advancing the stylet 92 to cause the projections of the anchoring device 100 to pierce the obstructing member 90 and the wall of the air passageway 50. This engagement by piercing anchors the obstructing member 90 in the air passageway 50.
  • FIG. 5 illustrates the obstructing device anchored in place within an air passageway by the anchoring device, in accordance with the invention.
  • Obstructing member 90 has expanded upon placement in the air passageway 50 to loosely seal the air passageway 50. This causes the lung portion 66 to be maintained in a permanently collapsed state.
  • the obstructing member 90 may be any shape suitable for accomplishing its purpose, and may be a solid member or a membrane.
  • Anchoring device 100 has anchored obstructing member 90 in place by engaging both the obstructing member 90 and the wall of air passageway 50.
  • the obstructing member 90 has an outer dimension 91, and when expanded, enables a contact zone with the air passageway inner dimension 51. This seals the air passageway upon placement of the obstructing member 90 in the air passageway 50 for maintaining the lung portion 66 in the collapsed state.
  • the projections of the anchor 100 have engaged the obstructing member 90 and the wall of air passageway 50 by piercing into both. This engagement anchors obstructing member 90 against movement distally or proximally, such as might be caused by breathing, sneezing, coughing or gasping.
  • the lung portion 66 may be collapsed or reduced in volume using a vacuum prior to placement of obstructing member 90, or sealing the air passageway 50 with obstructing member 90 may collapse it. Over time, the air within the lung portion 66 will be absorbed by the body and result in the collapse of lung portion 66.
  • obstructing member 90 may include the function of a one-way valve that allows air to escape from lung portion 66. Lung portion 66 will then collapse, and the valve will prevent air from being inhaled.
  • FIG. 6 is a perspective view of an anchoring device, as the device would appear when fully deployed in an air passageway, in accordance with the present invention.
  • Anchoring device 100 includes a base 101, support members 102, 104, 106, and 108; projections 112, 114, 116, and 118; projection ends 122, 124, 126, and 128; and stops 132, 134, 136, and 138.
  • the base 101 of anchoring device 100 carries support members 102, 104, 106, and 108.
  • the support members 102, 104, 106, and 108 carry projections 112, 114, 116, and 118, and projection ends 122, 124, 126, and 128, respectively.
  • Base 101 carries support members 102, 104, 106, and 108.
  • the support members 102, 104, 106, and 108 carry projections 112, 114, 116, and 118, and projection ends 122, 124, 126, and 128, respectively.
  • 101 is a tubular member, preferably hypodermic needle tubing.
  • Support members 102, 104, 106, and 108 are coupled mechanically to base 101, such as by crimping, or by other methods such as adhesive or welding. Support members 102,
  • the support members are preferably formed of stainless steel, Nitinol, or other suitable material having a memory of its original shape, and resiliency to return the material to that shape.
  • the support members and anchors may be formed by laser cutting a single tubular member, such as hypodermic needle tubing, lengthwise and bending the support members to the appropriate shape .
  • Projections 112, 114, 116, and 118 are portions of support members 102, 104, 106, and 108, respectively, and are at an end opposite to the end coupled to base 101.
  • the support members and the projections are formed in a configuration that will result in the memory and resiliency of their material moving at least the projections proximally upon deployment to a position to engage the obstructing member and the air passageway wall by piercing.
  • the configuration is a curve having a decreasing radius toward the projection ends, such that the projection ends will pierce the air passageway wall at an angle that provides sufficient shear resistance to anchor the obstructing member.
  • Projection ends 122, 124, 126, and 128 are shaped to promote piercing of an obstructing member and an air passageway wall.
  • Stops 132, 134, 136, and 138 are shaped and dimensioned to limit the piercing by the projections, and generally consist of a widened area such as a shoulder between support members 102, 104, 106, and 108, and projections 112, 114, 116, and 118, respectively.
  • the stops may be formed from the same material as the support member and its projection, or in an alternative embodiment, may be formed separately and coupled to the support member.
  • base 101, support members 102, 103, 104, 105, 106, and 108, projections 112, 114, 116, and 118, projection ends 122, 124, 126, and 128, and stops 132, 134, 136, and 138 may be formed by laser cutting a single tubular member lengthwise, and bending the support members and projections to a required shape.
  • the tubular member is preferably hypodermic needle tubing, or may be stainless steel, Nitinol, or other suitable material having a memory of its original shape and resiliency to return the material to that shape.
  • FIG. 7 is a perspective view of an intra-bronchial device comprising an obstructing member and the anchoring device of FIG. 6 anchored in an air passageway, in accordance with the present invention.
  • Intra-bronchial device 140 comprises obstructing member 90 and anchoring device 100.
  • the obstructing member 90 illustrated includes a flexible membrane having an interior and exterior surface, open in the proximal direction, and may be formed of silicone, polyethylene, polyurethane, or other elastomeric material, for example.
  • Obstructing member 90 may be carried on a support structure. In an alternative embodiment, obstructing member 90 may be a solid member.
  • FIG. 7 illustrates the obstructing member 90 anchored by the anchoring device 100.
  • Projections 112, 114, 116, and 118 of anchoring device 100 engage obstructing member 90 and the air passageway wall 130 by piercing. This anchors the obstructing member 90 to the air passageway wall 130.
  • the piercing is limited by stops 132, 134, 136, and 138. However, because of the perspective, only projections 112 and 116, and only stop 138 are visible.
  • Obstructing member 90 is collapsible for insertion into an internal lumen of a catheter.
  • Obstructing member 90 is inserted into the catheter lumen, which is typically already placed in the air passageway 50 as generally illustrated in FIG. 3.
  • Obstructing member 90 is advanced down the catheter lumen by a stylet into the air passageway 50 to where the obstructing member 90 is to be deployed.
  • obstructing member 90 is released from the catheter and expands to assume its deployed shape as generally illustrated in FIG. 7.
  • obstructing member 90 forms a contact zone 129 with the wall 130 of the air passageway 50 to prevent air from being inhaled into the lung portion to collapse the lung portion.
  • Obstructing member 90 may be loosely deployed such that it expands on inhalation to form a seal against a wall of the air passageway 130, and slightly contracts on exhalation to allow air and mucus transport from the collapsed lung portion. This provides a one-way valve function.
  • Anchoring device 100 is collapsed into a first position for insertion into the internal lumen of a catheter, which may be the same catheter that placed the obstructing member 90.
  • Anchoring device 100 is inserted into the catheter lumen and advanced down the catheter lumen by pushing the stylet against base 101.
  • Anchoring device 100 is advanced into the air passageway 50 to where it is to be deployed in proximity to obstructing member 90 as generally illustrated in FIGS. 4 and 5.
  • projections 112, 114, 116, and 118 are urged peripherally by the memory and resiliency of the material of support members 102, 104, 106, and 108.
  • Anchoring device 100 is further advanced by the stylet pushing against base 101, which imparts a force on the projections 122, 124, 126, and 128, and urges the projections to engage the obstructing member 90 and the air passageway wall 130 by piercing.
  • the anchors pierce into and become embedded in the wall 130 of the air passageway 50, preferably without piercing through the wall 130.
  • Stops 132, 134, 136, and 138 limit the piercing of the air passageway wall 130 by engaging obstructing member 90. This brings anchoring device 100 into its second position engaging the obstructing member 90 and the air passageway wall 130 to anchor obstructing member 90.
  • the stops pierce the air passageway wall in the contact zone 129.
  • the anchoring device 100 is self-deploying.
  • the memory and resiliency of the material of support members 102, 104, 106, and 108 provide sufficient urgency to force projections 122, 124, 126, and 128 to engage the obstructing member 90 and the air passageway wall 130 by piercing.
  • the preclusion of air from being inhaled into the lung portion may be terminated by eliminating the obstructing effect of intra-bronchial device 140.
  • the preclusion of air by the embodiment illustrated in FIG. 7 may be eliminated by releasing projections 112, 114, 116, and 118 from the air passageway wall 130.
  • the anchors may be released by inserting a catheter into air passageway 50 in proximity to anchor device 100.
  • a retractor device which may be biopsy forceps or other device capable of gripping a portion of anchor device 100, is inserted in the catheter.
  • the forceps are used to engage a portion of the anchor device 100, preferably base 101, and draw it toward the catheter.
  • the drawing action releases projections 112, 114, 116, and 118 from air passageway wall 130 and the obstructing member 90.
  • the anchoring device 100 is drawn into the catheter with the forceps, causing the support members 102, 104, 106, and 108, and projections 112, 114, 116, and 118 to collapse into the first position.
  • the collapsed anchoring device 100 now fully enters the catheter lumen for removal from the patient .
  • the retractor device is then reinserted in the catheter.
  • the forceps are used to engage obstructing member 90 and draw it toward the catheter.
  • the drawing action releases obstructing member 90 from air passageway wall 130.
  • the obstructing member 90 is then further drawn into the catheter with the forceps, causing it to collapse and fully enter the catheter lumen for removal from the patient .
  • FIG. 8 is a perspective view of an annular anchoring device, as the device would appear when fully deployed in an air passageway in accordance with the present invention.
  • Annular anchoring device 150 includes annular member 162; periphery 164; aperture 152; projections 172, 174, 176, and 178; projection ends 182, 184, 186, and 188; and stops 192a-b, 194a-b, 196a-b, and 198a-b.
  • Annular member 162 has a periphery 164 and an aperture 152.
  • Annular member 162 carries projections 172, 174, 176, and 178 on its periphery 164.
  • Projection ends 182, 184, 186, and 188 are shaped to promote piercing of an obstructing member and an air passageway wall by the projections.
  • Stops 192a-b, 194a-b, 196a-b, and 198a-b may be formed on the periphery 164 of annular member 162 adjacent to projections 172, 174, 176, and 178, respectively.
  • the "a" stop and the "b” stop are disposed on opposite sides of a projection.
  • Stops 192a-b, 194a-b, 196a-b, and 198a-b are shaped and dimensioned to limit the piercing of an obstructing member and an air passageway wall by the projections.
  • Annular anchoring device 150 is made from stainless steel, Nitinol, or other suitable material having a memory of its original shape and resiliency to return the material to that shape. In an embodiment, annular anchoring device 150 is formed from a single piece of material, such as laser cutting, stamping, or other methods as are known to those in the art.
  • Annular anchoring device 150 may have any cross-sectional shape compatible with its material and layout, which may be flat, elliptical, or rectangular.
  • the number of projections, and the shape and configuration of the projection, may be selected as will provide sufficient engagement to anchor obstructing member 90.
  • the projections and their ends are arranged to frictionally engage without piercing.
  • the projections may be divided into sets, one set arranged to pierce and another set arranged not to pierce.
  • One set of projections of this embodiment is further arranged to engage only the obstructing member 90 and the another set is arranged to engage only the air passageway wall 130.
  • FIG. 9 is a perspective view of an intra-bronchial device comprising an obstructing member and the annular anchoring device of FIG. 8 anchored in an air passageway, in accordance with the present invention.
  • Intra-bronchial device 200 comprises obstructing member 90 and annular anchoring device 150.
  • FIG. 9 illustrates the obstructing member 90 anchored by the anchoring device 150.
  • anchoring device 150 engages obstructing member 90 and the air passageway wall 130 by piercing. This anchors the obstructing member 90 to the air passageway wall 130.
  • the piercing is limited by stops 192a-b, 194a-b, 196a-b, and 198a- b. However, because of the perspective, projection 178 is not visible, and stops 192a-b, 194a-b, 196a-b are not visible.
  • Obstructing member 90 is placed in air passageway 50 in the manner described in conjunction with FIG. 7.
  • anchoring device 150 is provided in a collapsed configuration, which is a first position, and is balloon expandable.
  • anchoring device 150 may be collapsed into the first position by gripping opposed portions of periphery 164 with forceps, and drawing the portions toward each other. Anchoring device 150 in the first position is inserted into the internal lumen of a catheter, which may be the same catheter that placed the obstructing member 90. Anchoring device 150 is advanced down the catheter lumen placed into the air passageway 50 by pushing the stylet. Anchoring device 150 is advanced to where it is to be deployed in proximity to obstructing member 90 as generally illustrated in FIGS. 4 and 5.
  • Anchoring device 150 is released from the catheter in proximity to obstructing member 90, such that when anchoring device is expanded, projections 172, 174, 176, and 178 move peripherally into a second position and engage obstructing member 90 and air passageway wall 130.
  • the deployment includes expanding anchoring device 150 by a balloon catheter. The expansion of anchoring device 150 urges the projections 172, 174, 176, and 178 into engagement with the obstructing member 90 and the air passageway wall 130 by piercing, preferably without projecting through the wall 130.
  • Stops 192a-b, 194a-b, 196a-b, and 198a-b limit the piercing of the air passageway wall 130 by engaging obstructing member 90.
  • the deployment includes expansion by the memory and resiliency of the material of anchoring device 150 urging the projections 172, 174, 176, and 178 to engage the obstructing member 90' and the air passageway wall 130.
  • the expansion may be provided or supplemented by a device deployed through the catheter that engages and expands aperture 152 to move anchoring device 150 into its deployed, or second position.
  • the preclusion of air from being inhaled into the lung portion may be terminated by eliminating the obstructing effect of intra-bronchial device 200.
  • the preclusion of air by the embodiment illustrated in FIG. 9 may be eliminated by releasing projections 172, 174, 176, and 178 from the air passageway wall 130.
  • the anchors may be released by inserting a catheter into air passageway 50 in proximity to anchor device 150.
  • a retractor device, such as biopsy forceps, capable of gripping a portion of annular anchor device 150 is inserted in the catheter. The forceps are used to engage anchor device 150 and collapse it.
  • Anchor device 150 can be collapsed by centrally moving opposing portions of the periphery 164 with the forceps to move anchor device 150 into the first position.
  • FIG. 10 is a plan view of the annular anchoring device of FIG.
  • Annular anchoring device 150 is illustrated fully expanded and deployed into obstructing member 90.
  • Projections 172, 174, 176, and 178 are illustrated having pierced through obstructing member 90, with the piercing limited by stops 192a-b, 194a-b, 196a-b, and 198a-b.

Abstract

An intra-bronchial device may be placed in an air passageway of a patient to collapse a lung portion associated with the air passageway. The device includes an obstructing member (40) that prevents air from being inhaled into the lung portion to collapse the lung portion, and an anchoring device (100) that anchors the obstructing member in the air passageway by engaging the obstructing member (90) and the air passageway wall. The anchoring device (100) may frictionally engage the obstructing member and the air passageway, or engage both by piercing. The engagement provided by the anchoring device may be releasable for removal of the obstructing member (90). The anchoring device (100) may be balloon expandable from a first shape to a second shape that engages the obstructing member (90) and the air passageway. The obstructing member (90) may be a one-way valve.

Description

REMOVABLE ANCHORED LUNG VOLUME REDUCTION DEVICES .AND METHODS
Background
[1] The present invention is generally directed to a removable anchored device, system, and method for treating Chronic Obstructive Pulmonary Disease (COPD) . The present invention is more particularly directed to providing an anchored intra-bronchial obstruction that may be removable. [2] COPD has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structural abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia, and smooth muscle hypertrophy in terminal bronchioles .
[3] The incidence, prevalence, and health-related costs of COPD are on the rise. Mortality due to COPD is also on the rise. In 1991, COPD was the fourth leading cause of death in the United States and had increased 33% since 1979. COPD affects the patient's whole life, producing increasing disability. It has three main symptoms: cough; breathlessness; and wheeze. At first, breathlessness may be noticed when running for a bus, digging in the garden, or walking uphill. Later, it may be noticed when simply walking in the kitchen. Over time, it may occur with less and less effort until it is present all of the time. COPD is a progressive disease and currently has no cure. Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below. [4] The prevention of further respiratory damage entails the adoption of a healthy lifestyle. Smoking cessation is believed to be the single most important therapeutic intervention. However, regular exercise and weight control are also important. Patients whose symptoms restrict their daily activities or who otherwise have an impaired quality of life may require a pulmonary rehabilitation program including ventilatory muscle training and breathing retraining. Long- term oxygen therapy may also become necessary. [5] Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled beta- agonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, ipratropium bromide may be indicated. Further, courses of steroids, such as corticosteroids, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pneumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD. [6] About 40 years ago, it was first postulated that the tethering force that tends to keep the intrathoracic airways open was lost in emphysema and that by surgically removing the most affected parts of the lungs, the force could be partially restored. Although the surgery was deemed promising, the lung volume reduction surgery (LVRS) procedure was abandoned. LVRS was later revived. In the early 1990' s, hundreds of patients underwent the procedure. However, the number of procedures declined because Medicare stopping reimbursing for LVRS. The procedure is currently under review in controlled clinical trials. However, preliminary data indicates that patients benefit from the procedure in terms of an increase in forced expiratory volume, a decrease in total lung capacity, and a significant improvement in lung function, dyspnea, and quality of life. Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms; enhanced elastic lung recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricular filling.
[7] Lastly, lung transplantation is also a therapeutic option. Today, COPD is the most common diagnosis for which lung transplantation is considered. Unfortunately, this consideration is given for only those with advanced COPD. Given the limited availability of donor organs, lung transplant is far from being available to all patients. [8] There is a need for additional non-surgical options for permanently treating COPD without surgery. A promising new therapy includes non-surgical apparatus and procedures for lung volume reduction by permanently obstructing the air passageway that communicates with the portion of the lung to be collapsed. The therapy includes placing an obstruction in the air passageway that prevents inhaled air from flowing into the portion of the lung to be collapsed. This provides lung volume reduction with concomitant improved pulmonary function without the need for surgery. The effectiveness of obstructions may be enhanced if it is anchored in place. The effectiveness may also be enhanced if the obstruction is removable. However, no readily available apparatus and method exists for anchoring the obstruction, and for removal if required.
[9] In view of the foregoing, there is a need in the art for a new and improved apparatus and method for permanently obstructing an air passageway that is anchored in place, and that may be removed if required. The present invention is directed to a device, system, and method that provide such an improved apparatus and method for treating COPD. Summary [10] The present invention provides an intra-bronchial device for placement in an air passageway of a patient to collapse a lung portion associated with the air passageway. The device includes an obstructing member that prevents air from being inhaled into the lung portion to collapse the lung portion, and an anchoring device that anchors the obstructing member in the air passageway by engaging the obstructing member and the air passageway wall. The anchoring device may frictionally engage the obstructing member. The engagement provided by the anchoring device may be releasable for removal of the obstructing member. The anchoring device may comprise a material having a memory of an original undistorted shape, and a resiliency to return the material from a distorted shape to the original undistorted shape. The anchoring device may be balloon expandable from a first shape to a second shape that engages the obstructing member and the air passageway. The obstructing member may be a one-way valve. [11] An alternative embodiment of the present invention provides an intra-bronchial device for placement in an air passageway of a patient to collapse a lung portion associated with the air passageway. The device includes an obstructing member that prevents air from being inhaled into the lung portion to collapse the lung portion, and an anchoring device having a projection that anchors the obstructing member in the air passageway by piercingly engaging the obstructing member and the air passageway wall. The engagement provided by the anchoring device may be releasable for removal of the obstructing member. The anchoring device may comprise a material having a memory of an original undistorted shape, and a resiliency to return the material from a distorted shape to the original undistorted shape. The anchoring device may be balloon expandable from a compressed shape to a deployed shape that engages the obstructing member and the air passageway wall . The anchoring device may be configured to urge engagement with the air passageway wall. The projection may be releasable from the air passageway wall for removal of the anchoring device. The projection may include a stop dimensioned to limit the piercing. At least a portion of the anchoring device may be collapsible for placement in the air passageway. The anchoring device may collapse centrally. The anchoring device may include a projection that collapses centrally. The anchoring device may be configured to move from a first position to a second position to anchor the obstructing member in the air passageway. The anchoring device may be configured to move from a first position to a second position to anchor the obstructing member in the air passageway, and to move from the second position to the first position to disengage the obstructing member for removal from the air passageway. The obstructing member may be a one-way valve . [12] Another alternative embodiment provides a method of reducing the size of a lung by collapsing a portion of the lung. The method includes the step of providing an intra- bronchial device having an obstructing member which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and an anchoring device that anchors the obstructing member in the air passageway by engaging the obstructing member and the wall of the air passageway. The method also includes the steps of placing the obstructing member in the air passageway, placing the anchoring device in the air passageway, and deploying the anchoring device. The anchoring device may include a projection that piercingly engages the obstructing member and the air passageway wall. The anchoring device may be releasable for removal of the intra-bronchial device. The obstructing member may form a one-way valve. At least a portion of the anchoring device may be collapsible.
[13] A further embodiment provides a method of reducing the size of a lung by collapsing a portion of the lung. The method includes the step of providing an intra-bronchial device having an obstructing member which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and an anchoring device that anchors the obstructing member in the air passageway by engaging the obstructing member and the wall of the air passageway. The method also includes the steps of placing the obstructing member in the air passageway, placing the anchoring device in the air passageway, deploying the anchoring device, removing the anchoring device, and removing the obstructing member. The anchoring device may include a projection that piercingly engages the obstructing member and the air passageway wall. The anchoring device may include a projection that piercingly engages the obstructing member and the air passageway wall.
The projection may be releasable from the air passageway wall for removal of the anchoring device, and the step of removing the anchoring device includes releasing the projection. The obstructing member may form a one-way valve. A portion of the anchoring device may be collapsible.
[14] Yet another embodiment provides an air passageway obstructing device having obstructing means for obstructing air flow within the air passageway, and anchoring means for anchoring the obstructing means within an air passageway by engaging the obstructing means and the air passageway, and the anchoring means being further releasable for removal of the obstructing means. [15] These and various other features as well as advantages which characterize the present invention will be apparent from a reading of the following detailed description and a review of the associated drawings.
Brief Description of the Drawings
[16] The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like referenced numerals identify identical elements, and wherein: [17] Figure 1 is a simplified sectional view of a thorax illustrating a healthy respiratory system;
[18] Figure 2 is a sectional view similar to FIG. 1, but illustrating a respiratory system suffering from COPD, and the execution of a first step in treating the COPD condition by reducing the size of a lung portion in accordance with the present invention;
[19] Figure 3 is perspective view, partially in section, and to an enlarged scale, illustrating an intermediate step in the treatment; [20] Figure 4 illustrates an anchoring device being delivered through a catheter for placement in proximity to the obstructing member and deployment, in accordance with the invention;
[21] Figure 5 illustrates the obstructing device anchored in place within an air passageway by the anchoring device, in accordance with the invention; [22] Figure 6 is a perspective view of an anchoring device, as the device would appear when fully deployed in an air passageway, in accordance with the present invention; [23] Figure 7 is a perspective view of an intra-bronchial device comprising an obstructing member and the anchoring device of FIG. 6 anchored in an air passageway in accordance with the present invention;
[24] Figure 8 is a perspective view of an annular anchoring device as the device would appear when fully deployed in an air passageway, in accordance with the present invention;
[25] Figure 9 is a perspective view of an intra-bronchial device comprising an obstructing member and the annular anchoring device of FIG. 8 anchored in an air passageway, in accordance with the present invention; and
[26] Figure 10 is a plan view of the annular anchoring device of FIG. 8 engaged in the proximal end of an obstructive device, in accordance with the present invention.
Detailed Description [27] In the following detailed description of exemplary embodiments of the invention, reference is made to the accompanying drawings that form a part hereof. The detailed description and the drawings illustrate specific exemplary embodiments by which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention. It is understood that other embodiments may be utilized, and other changes may be made, without departing from the spirit or scope of the present invention. The following detailed description is therefore not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims. [28] Throughout the specification and claims, the following terms take the meanings explicitly associated herein unless the context clearly dictates otherwise. The meaning of "a", "an", and "the" include plural references. The meaning of "in" includes "in" and "on." Referring to the drawings, like numbers indicate like parts throughout the views. Additionally, a reference to the singular includes a reference to the plural unless otherwise stated or inconsistent with the disclosure herein. [29] Additionally, throughout the specification, claims, and drawings, the term "proximal" means nearest the trachea, and "distal" means nearest the bronchioles.
[30] Briefly stated, an anchored intra-bronchial device is provided for placement in an air passageway of a patient to collapse or reduce ventilation to a lung portion associated with the air passageway. An obstructing member is first placed in the air passageway, and then an anchoring device is deployed which anchors the obstructing member in place. A further aspect of the invention provides removability of the intra-bronchial device by releasing the anchoring device for removal of the obstructing member.
[31] FIG. 1 is a sectional view of a healthy respiratory system. The respiratory system 20 resides within the thorax 22 that occupies a space defined by the chest wall 24 and the diaphragm 26.
[32] The respiratory system 20 includes the trachea 28, the left mainstem bronchus 30, the right mainstem bronchus 32, the bronchial branches 34, 36, 38, 40, and 42 and sub-branches 44, 46, 48, and 50. The respiratory system 20 further includes left lung lobes 52 and 54 and right lung lobes 56,
58, and 60. Each bronchial branch and sub-branch communicates with a respective different portion of a lung lobe, either the entire lung lobe, a segment, or a portion thereof. As used herein, the term "air passageway" is meant to denote either bronchi or bronchioles, and typically means a bronchus branch or sub-branch that communicates with a corresponding individual lung lobe, segment, or lung lobe tissue portion to provide inhaled air thereto or conduct exhaled air therefrom. [33] Characteristic of a healthy respiratory system is the arched or inwardly arcuate diaphragm 26. As the individual inhales, the diaphragm 26 straightens to increase the volume of the thorax 22. This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes .
[34] In contrast to the healthy respiratory system of FIG. 1, FIG. 2 illustrates a respiratory system suffering from COPD. Here it may be seen that the lung lobes 52, 54, 56, 58, and 60 are enlarged and that the diaphragm 26 is not arched but substantially straight. Hence, this individual is incapable of breathing normally by moving diaphragm 28. Instead, in order to create the negative pressure in thorax 22 required for breathing, this individual must move the chest wall outwardly to increase the volume of the thorax. This results in inefficient breathing causing these individuals to breathe rapidly with shallow breaths.
[35] It has been found that the apex portions 62 and 66 of the upper lung lobes 52 and 56, respectively, are most affected by COPD. Hence, bronchial sub-branch obstructing devices are generally employed for treating the apex 66 of the right, upper lung lobe 56. However, as will be appreciated by those skilled in the art, the present invention may be applied to any lung portion without departing from the present invention. As will be further appreciated by those skilled in the art, the present invention may be used with any type of obstructing member to provide an anchored obstructing device, which may be removed. The inventions disclosed and claimed in United States Patent Numbers 6,258,100 and 6,293,951, both of which are incorporated herein by reference, provide an improved therapy for treating COPD by obstructing an air passageway using an intra-bronchial valve or plug. The present invention may be used with the apparatus, system, and methods of these patents as will be briefly described in conjunction with the disclosure of the preferred embodiments of the present invention. [36] The insertion of an obstructing member treats COPD by deriving the benefits of lung volume reduction surgery without the need of performing the surgery. The treatment contemplates permanent partial or complete collapse of a lung portion to reduce the volume of lung mass. This leaves extra volume within the thorax for the diaphragm to assume its arched state for acting upon the remaining healthier lung tissue. As previously mentioned, this should result in improved pulmonary function due to enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricle filling. The present invention supports the use of intra-bronchial plugs to treat COPD by anchoring the obstructing member in the air passageway. The present invention further supports the use of intra-bronchial plugs by providing for their removal if necessary. Use of anchors can allow the obstructing member to be relatively loosely fitted against the air passageway wall, which may provide increased mucociliary transport of mucus and debris out of the collapsed lung portion. [37] FIG. 2 also illustrates a step in COPD treatment using an obstructing member using a bronchoscope or catheter. The invention disclosed herein is not limited to use with the particular method illustrated herein. Catheter 70 may be used alone to perform the insertion, may be extended from a bronchoscope, or used in conjunction with a bronchoscope. For purposes of this description, the insertion will be described with reference to only the catheter 70. Treatment is initiated by feeding a conduit or catheter 70 down the trachea 28, into the right mainstem bronchus 32, into the bronchial branch 42 and into and terminating within the sub-branch 50. The sub-branch 50 is the air passageway that communicates with the lung portion 66 to be treated, and is also referred to herein as air passageway 50. The catheter 70 is preferably formed of flexible material such as polyethylene. Also, the catheter 70 is preferably preformed with a bend 72 (or capable of bending) to assist the feeding of the catheter from the right mainstem bronchus 32 into the bronchial branch 42, or could be deformed to conform to different curvature and angles of a bronchial tree.
[38] FIG. 3 illustrates a further step in a method for inserting an obstructing member 90 in a bronchial sub-branch using a catheter or a bronchoscope. Catheter 70 may include an optional inflatable sealing member 74 for use with a vacuum to collapse lung portion 66 prior to insertion of obstructing member 90. The obstructing member 90 may be formed of resilient or collapsible material to enable the obstructing member 90 to be fed through the conduit 70 in a collapsed state. A stylet or biopsy forceps, hereafter referred to as a stylet 92, is used to push the obstructing member 90 to the end 77 of the catheter 70 for inserting the obstructing member 90 within the air passageway 50 adjacent to the lung portion 66 to be permanently collapsed. Optional sealing member 74 is withdrawn after obstructing member 90 is inserted. [39] A function of the intra-bronchial device disclosed and claimed in this specification, including the detailed description and the claims, is described in terms of collapsing a lung portion associated with an air passageway to reduce lung volume . In some lungs , a portion of a lung may receive air from collateral air passageways. Obstructing one of the collateral air passageways may reduce the volume of the lung portion associated with the air passageway, but not completely collapse the lung portion as that term may be generally understood. As used in the description and claims herein, the meaning of "collapse" includes both a complete collapse of a lung portion and a partial collapse of a lung portion.
[40] Once deployed, the obstructing member precludes inhaled air from entering the lung portion to be collapsed. In accordance with the present invention, it is preferable that the obstructing member takes the form of a one-way valve. In addition to precluding inhaled air from entering the lung portion, the member further allows air within the lung portion to be exhaled. This results in more rapid collapse of the lung portion. In addition, anchoring obstructing members that preclude both inhaled and exhaled airflow are contemplated as within the scope of the invention.
[41] FIG. 4 illustrates an anchoring device being delivered through a catheter for placement in proximity to the obstructing member and deployment, in accordance with the invention. A previously compressed anchoring device 100 is pushed by stylet 92 to the end 77 of the catheter 70 for placement in proximity to the obstructing member 90. As anchoring device 100 is pushed from the catheter 70 into place and into proximity with the obstructing member 90, the resiliency of the anchor projections moves them peripherally. Anchoring device 100 is deployed by further advancing the stylet 92 to cause the projections of the anchoring device 100 to pierce the obstructing member 90 and the wall of the air passageway 50. This engagement by piercing anchors the obstructing member 90 in the air passageway 50. [42] FIG. 5 illustrates the obstructing device anchored in place within an air passageway by the anchoring device, in accordance with the invention. Obstructing member 90 has expanded upon placement in the air passageway 50 to loosely seal the air passageway 50. This causes the lung portion 66 to be maintained in a permanently collapsed state. The obstructing member 90 may be any shape suitable for accomplishing its purpose, and may be a solid member or a membrane. Anchoring device 100 has anchored obstructing member 90 in place by engaging both the obstructing member 90 and the wall of air passageway 50.
[43] More specifically, the obstructing member 90 has an outer dimension 91, and when expanded, enables a contact zone with the air passageway inner dimension 51. This seals the air passageway upon placement of the obstructing member 90 in the air passageway 50 for maintaining the lung portion 66 in the collapsed state. The projections of the anchor 100 have engaged the obstructing member 90 and the wall of air passageway 50 by piercing into both. This engagement anchors obstructing member 90 against movement distally or proximally, such as might be caused by breathing, sneezing, coughing or gasping. [44] Alternatively, the lung portion 66 may be collapsed or reduced in volume using a vacuum prior to placement of obstructing member 90, or sealing the air passageway 50 with obstructing member 90 may collapse it. Over time, the air within the lung portion 66 will be absorbed by the body and result in the collapse of lung portion 66. Alternatively, obstructing member 90 may include the function of a one-way valve that allows air to escape from lung portion 66. Lung portion 66 will then collapse, and the valve will prevent air from being inhaled.
[45] FIG. 6 is a perspective view of an anchoring device, as the device would appear when fully deployed in an air passageway, in accordance with the present invention. Anchoring device 100 includes a base 101, support members 102, 104, 106, and 108; projections 112, 114, 116, and 118; projection ends 122, 124, 126, and 128; and stops 132, 134, 136, and 138.
[46] The base 101 of anchoring device 100 carries support members 102, 104, 106, and 108. The support members 102, 104, 106, and 108 carry projections 112, 114, 116, and 118, and projection ends 122, 124, 126, and 128, respectively. Base
101 is a tubular member, preferably hypodermic needle tubing.
Support members 102, 104, 106, and 108, are coupled mechanically to base 101, such as by crimping, or by other methods such as adhesive or welding. Support members 102,
104, 106, and 108 are generally similar to each other. The support members are preferably formed of stainless steel, Nitinol, or other suitable material having a memory of its original shape, and resiliency to return the material to that shape. The support members and anchors may be formed by laser cutting a single tubular member, such as hypodermic needle tubing, lengthwise and bending the support members to the appropriate shape .
[47] Projections 112, 114, 116, and 118 are portions of support members 102, 104, 106, and 108, respectively, and are at an end opposite to the end coupled to base 101. The support members and the projections are formed in a configuration that will result in the memory and resiliency of their material moving at least the projections proximally upon deployment to a position to engage the obstructing member and the air passageway wall by piercing. In this preferred embodiment, the configuration is a curve having a decreasing radius toward the projection ends, such that the projection ends will pierce the air passageway wall at an angle that provides sufficient shear resistance to anchor the obstructing member. The angle is a function of the design parameters of anchor device 100, and the more near perpendicular the angle is, the better the shear resistance will be. Projection ends 122, 124, 126, and 128 are shaped to promote piercing of an obstructing member and an air passageway wall. Stops 132, 134, 136, and 138, are shaped and dimensioned to limit the piercing by the projections, and generally consist of a widened area such as a shoulder between support members 102, 104, 106, and 108, and projections 112, 114, 116, and 118, respectively. The stops may be formed from the same material as the support member and its projection, or in an alternative embodiment, may be formed separately and coupled to the support member.
[48] In an alternative embodiment, base 101, support members 102, 103, 104, 105, 106, and 108, projections 112, 114, 116, and 118, projection ends 122, 124, 126, and 128, and stops 132, 134, 136, and 138, may be formed by laser cutting a single tubular member lengthwise, and bending the support members and projections to a required shape. The tubular member is preferably hypodermic needle tubing, or may be stainless steel, Nitinol, or other suitable material having a memory of its original shape and resiliency to return the material to that shape.
[49] FIG. 7 is a perspective view of an intra-bronchial device comprising an obstructing member and the anchoring device of FIG. 6 anchored in an air passageway, in accordance with the present invention. Intra-bronchial device 140 comprises obstructing member 90 and anchoring device 100. The obstructing member 90 illustrated includes a flexible membrane having an interior and exterior surface, open in the proximal direction, and may be formed of silicone, polyethylene, polyurethane, or other elastomeric material, for example. Obstructing member 90 may be carried on a support structure. In an alternative embodiment, obstructing member 90 may be a solid member. [50] FIG. 7 illustrates the obstructing member 90 anchored by the anchoring device 100. Projections 112, 114, 116, and 118 of anchoring device 100 engage obstructing member 90 and the air passageway wall 130 by piercing. This anchors the obstructing member 90 to the air passageway wall 130. The piercing is limited by stops 132, 134, 136, and 138. However, because of the perspective, only projections 112 and 116, and only stop 138 are visible.
[51] Obstructing member 90 is collapsible for insertion into an internal lumen of a catheter. Obstructing member 90 is inserted into the catheter lumen, which is typically already placed in the air passageway 50 as generally illustrated in FIG. 3. Obstructing member 90 is advanced down the catheter lumen by a stylet into the air passageway 50 to where the obstructing member 90 is to be deployed. Once the point of deployment is reached, obstructing member 90 is released from the catheter and expands to assume its deployed shape as generally illustrated in FIG. 7. Upon deployment, obstructing member 90 forms a contact zone 129 with the wall 130 of the air passageway 50 to prevent air from being inhaled into the lung portion to collapse the lung portion.
Obstructing member 90 may be loosely deployed such that it expands on inhalation to form a seal against a wall of the air passageway 130, and slightly contracts on exhalation to allow air and mucus transport from the collapsed lung portion. This provides a one-way valve function.
[52] Anchoring device 100 is collapsed into a first position for insertion into the internal lumen of a catheter, which may be the same catheter that placed the obstructing member 90. Anchoring device 100 is inserted into the catheter lumen and advanced down the catheter lumen by pushing the stylet against base 101. Anchoring device 100 is advanced into the air passageway 50 to where it is to be deployed in proximity to obstructing member 90 as generally illustrated in FIGS. 4 and 5. Upon release from the catheter in proximity to obstructing member 90, projections 112, 114, 116, and 118 are urged peripherally by the memory and resiliency of the material of support members 102, 104, 106, and 108. Anchoring device 100 is further advanced by the stylet pushing against base 101, which imparts a force on the projections 122, 124, 126, and 128, and urges the projections to engage the obstructing member 90 and the air passageway wall 130 by piercing. The anchors pierce into and become embedded in the wall 130 of the air passageway 50, preferably without piercing through the wall 130. Stops 132, 134, 136, and 138 limit the piercing of the air passageway wall 130 by engaging obstructing member 90. This brings anchoring device 100 into its second position engaging the obstructing member 90 and the air passageway wall 130 to anchor obstructing member 90. In an alternative embodiment, the stops pierce the air passageway wall in the contact zone 129.
[53] In another alternative embodiment, the anchoring device 100 is self-deploying. The memory and resiliency of the material of support members 102, 104, 106, and 108 provide sufficient urgency to force projections 122, 124, 126, and 128 to engage the obstructing member 90 and the air passageway wall 130 by piercing. [54] The preclusion of air from being inhaled into the lung portion may be terminated by eliminating the obstructing effect of intra-bronchial device 140. The preclusion of air by the embodiment illustrated in FIG. 7 may be eliminated by releasing projections 112, 114, 116, and 118 from the air passageway wall 130. The anchors may be released by inserting a catheter into air passageway 50 in proximity to anchor device 100. A retractor device, which may be biopsy forceps or other device capable of gripping a portion of anchor device 100, is inserted in the catheter. The forceps are used to engage a portion of the anchor device 100, preferably base 101, and draw it toward the catheter. The drawing action releases projections 112, 114, 116, and 118 from air passageway wall 130 and the obstructing member 90. The anchoring device 100 is drawn into the catheter with the forceps, causing the support members 102, 104, 106, and 108, and projections 112, 114, 116, and 118 to collapse into the first position. The collapsed anchoring device 100 now fully enters the catheter lumen for removal from the patient . The retractor device is then reinserted in the catheter. The forceps are used to engage obstructing member 90 and draw it toward the catheter. The drawing action releases obstructing member 90 from air passageway wall 130. The obstructing member 90 is then further drawn into the catheter with the forceps, causing it to collapse and fully enter the catheter lumen for removal from the patient .
[55] FIG. 8 is a perspective view of an annular anchoring device, as the device would appear when fully deployed in an air passageway in accordance with the present invention. Annular anchoring device 150 includes annular member 162; periphery 164; aperture 152; projections 172, 174, 176, and 178; projection ends 182, 184, 186, and 188; and stops 192a-b, 194a-b, 196a-b, and 198a-b. [56] Annular member 162 has a periphery 164 and an aperture 152. Annular member 162 carries projections 172, 174, 176, and 178 on its periphery 164. Projection ends 182, 184, 186, and 188 are shaped to promote piercing of an obstructing member and an air passageway wall by the projections. Stops 192a-b, 194a-b, 196a-b, and 198a-b may be formed on the periphery 164 of annular member 162 adjacent to projections 172, 174, 176, and 178, respectively. The "a" stop and the "b" stop are disposed on opposite sides of a projection. Stops 192a-b, 194a-b, 196a-b, and 198a-b are shaped and dimensioned to limit the piercing of an obstructing member and an air passageway wall by the projections. In an alternative embodiment, the stops may form a shoulder completely around a perimeter of the projection. [57] Annular anchoring device 150 is made from stainless steel, Nitinol, or other suitable material having a memory of its original shape and resiliency to return the material to that shape. In an embodiment, annular anchoring device 150 is formed from a single piece of material, such as laser cutting, stamping, or other methods as are known to those in the art.
Annular anchoring device 150 may have any cross-sectional shape compatible with its material and layout, which may be flat, elliptical, or rectangular. The number of projections, and the shape and configuration of the projection, may be selected as will provide sufficient engagement to anchor obstructing member 90.
[58] In an alternative embodiment, the projections and their ends are arranged to frictionally engage without piercing. In a further alternative embodiment, the projections may be divided into sets, one set arranged to pierce and another set arranged not to pierce. One set of projections of this embodiment is further arranged to engage only the obstructing member 90 and the another set is arranged to engage only the air passageway wall 130.
[59] In a preferred embodiment, anchoring device 150 is arranged to be balloon expandable into its fully deployed configuration illustrated in FIG. 8. In an alternative embodiment, anchoring device 150 is arranged to be centrally collapsible for delivery through a catheter, and then expanded to its fully deployed configuration by the force of its resiliency or by an external force. [60] FIG. 9 is a perspective view of an intra-bronchial device comprising an obstructing member and the annular anchoring device of FIG. 8 anchored in an air passageway, in accordance with the present invention. Intra-bronchial device 200 comprises obstructing member 90 and annular anchoring device 150. FIG. 9 illustrates the obstructing member 90 anchored by the anchoring device 150. Projections 172, 174, 176, and 178 of anchoring device 150 engage obstructing member 90 and the air passageway wall 130 by piercing. This anchors the obstructing member 90 to the air passageway wall 130. The piercing is limited by stops 192a-b, 194a-b, 196a-b, and 198a- b. However, because of the perspective, projection 178 is not visible, and stops 192a-b, 194a-b, 196a-b are not visible. [61] Obstructing member 90 is placed in air passageway 50 in the manner described in conjunction with FIG. 7. In a preferred embodiment, anchoring device 150 is provided in a collapsed configuration, which is a first position, and is balloon expandable. In an alternative embodiment, anchoring device 150 may be collapsed into the first position by gripping opposed portions of periphery 164 with forceps, and drawing the portions toward each other. Anchoring device 150 in the first position is inserted into the internal lumen of a catheter, which may be the same catheter that placed the obstructing member 90. Anchoring device 150 is advanced down the catheter lumen placed into the air passageway 50 by pushing the stylet. Anchoring device 150 is advanced to where it is to be deployed in proximity to obstructing member 90 as generally illustrated in FIGS. 4 and 5. Anchoring device 150 is released from the catheter in proximity to obstructing member 90, such that when anchoring device is expanded, projections 172, 174, 176, and 178 move peripherally into a second position and engage obstructing member 90 and air passageway wall 130. In a preferred embodiment, the deployment includes expanding anchoring device 150 by a balloon catheter. The expansion of anchoring device 150 urges the projections 172, 174, 176, and 178 into engagement with the obstructing member 90 and the air passageway wall 130 by piercing, preferably without projecting through the wall 130. Stops 192a-b, 194a-b, 196a-b, and 198a-b limit the piercing of the air passageway wall 130 by engaging obstructing member 90. [62] In an alternative embodiment, the deployment includes expansion by the memory and resiliency of the material of anchoring device 150 urging the projections 172, 174, 176, and 178 to engage the obstructing member 90' and the air passageway wall 130. In a further alternative embodiment, the expansion may be provided or supplemented by a device deployed through the catheter that engages and expands aperture 152 to move anchoring device 150 into its deployed, or second position.
[63] The preclusion of air from being inhaled into the lung portion may be terminated by eliminating the obstructing effect of intra-bronchial device 200. The preclusion of air by the embodiment illustrated in FIG. 9 may be eliminated by releasing projections 172, 174, 176, and 178 from the air passageway wall 130. The anchors may be released by inserting a catheter into air passageway 50 in proximity to anchor device 150. A retractor device, such as biopsy forceps, capable of gripping a portion of annular anchor device 150 is inserted in the catheter. The forceps are used to engage anchor device 150 and collapse it. Anchor device 150 can be collapsed by centrally moving opposing portions of the periphery 164 with the forceps to move anchor device 150 into the first position. The collapsing releases projections 172, 174, 176, and 178 from the air passageway wall 130 and the obstructing member 90. The forceps are used to draw anchoring device 150 into the catheter. The collapsed anchoring device 150 is fully drawn into the catheter lumen for removal from the patient. The retractor device is then reinserted in the catheter. The forceps are used to engage obstructing member 90 and draw it toward the catheter. The drawing action releases obstructing member 90 from air passageway wall 130. The obstructing member 90 is then further drawn into the catheter with the forceps, causing it to collapse and fully enter the catheter lumen for removal from the patient. [64] FIG. 10 is a plan view of the annular anchoring device of FIG. 8 engaged in the proximal end of an obstructive device, in accordance with the present invention. Annular anchoring device 150 is illustrated fully expanded and deployed into obstructing member 90. Projections 172, 174, 176, and 178 are illustrated having pierced through obstructing member 90, with the piercing limited by stops 192a-b, 194a-b, 196a-b, and 198a-b.
[65] While particular embodiments of the present invention have been shown and described, modifications may be made. It is therefore intended in the appended claims to cover all such changes and modifications that fall within the true spirit and scope of the invention.

Claims

WHAT IS CLAIMED IS:
1. An intra-bronchial device for placement in an air passageway of a patient to collapse a lung portion associated with the air passageway, the device comprising: an obstructing member that prevents air from being inhaled into the lung portion to collapse the lung portion; and an anchoring device that anchors the obstructing member in the air passageway by engaging the obstructing member and the air passageway wall.
2. The intra-bronchial device of claim 1, wherein the engagement provided by the anchoring device is releasable for removal of the obstructing member.
3. The intra-bronchial device of claim 1, wherein the anchoring device comprises a material having a memory of an original undistorted shape, and a resiliency to return the material from a distorted shape to the original undistorted shape .
4. The intra-bronchial device of claim 1, wherein the anchoring device is balloon expandable from a compressed shape to a deployed shape, and the expansion to the deployed shape engages the obstructing member and the air passageway.
5. The intra-bronchial device of claim 1, wherein the anchoring device frictionally engages the obstructing member.
6. The intra-bronchial device of claim 1, wherein the obstructing member is a one-way valve.
7. An intra-bronchial device for placement in an air passageway of a patient to collapse a lung portion associated with the air passageway, the device comprising: an obstructing member that prevents air from being inhaled into the lung portion to collapse the lung portion; and an anchoring device having a projection that anchors the obstructing member in the air passageway by piercingly engaging the obstructing member and the air passageway wall.
8. The intra-bronchial device of claim 7, wherein the engagement provided by the anchoring device is releasable for removal of the obstructing member.
9. The intra-bronchial device of claim 7, wherein the anchoring device is configured to urge engagement with the air passageway wall.
10. The intra-bronchial device of claim 7, wherein the anchoring device comprises a material having a memory of an original undistorted shape, and a resiliency to return the material from a distorted shape to the original undistorted shape .
11. The intra-bronchial device of claim 7, wherein the anchoring device is balloon expandable from a compressed shape to a deployed shape, and expansion to the deployed shape engages the obstructing member and the air passageway wall .
12. The intra-bronchial device of claim 7, wherein the projection is releasable from the air passageway wall for removal of the anchoring device.
13. The intra-bronchial device of claim 7, wherein the projection includes a stop dimensioned to limit the piercing.
14. The intra-bronchial device of claim 7, wherein at least a portion of the anchoring device is collapsible for placement in the air passageway.
15. The intra-bronchial device of claim 14, wherein the anchoring device collapses centrally.
16. The intra-bronchial device of claim 14, wherein the anchoring device includes a projection that collapses centrally.
17. The intra-bronchial device of claim 7 , wherein the anchoring device is configured to move from a first position to a second position to anchor the obstructing member in the air passageway.
18. The intra-bronchial device of claim 7, wherein the anchoring device is configured to move from a first position to a second position to anchor the obstructing member in the air passageway, and to move from the second position to the first position to disengage the obstructing member for removal from the air passageway.
19. The intra-bronchial device of claim 7, wherein the obstructing member is a one-way valve.
20. A method of reducing the size of a lung by collapsing a portion of the lung, the method including the steps of: providing an intra-bronchial device comprising an obstructing member which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and an anchoring device that anchors the obstructing member in the air passageway by engaging the obstructing member and the wall of the air passageway when the anchoring device is deployed; placing the obstructing member in the air passageway; placing the anchoring device in the air passageway; and deploying the anchoring device.
21. The method of claim 20, wherein the anchoring device includes a projection that piercingly engages the obstructing member and the air passageway wall, and wherein the deploying step includes the further step of piercing.
22. The method of claim 20, wherein the anchoring device is releasable for removal of the intra-bronchial device.
23. The method of claim 20, wherein the obstructing member forms a one-way valve.
24. The method of claim 20, wherein at least a portion of the anchoring device is collapsible.
25. A method of reducing the size of a lung by collapsing a portion of the lung, the method including the steps of: providing an intra-bronchial device comprising an obstructing member which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and an anchoring device that anchors the obstructing member in the air passageway by engaging the obstructing member and the wall of the air passageway when the anchoring device is deployed; placing the obstructing member in the air passageway; placing the anchoring device in the air passageway; deploying the anchoring device; removing the anchoring device; and removing the obstructing member.
26. The method of claim 25, wherein the anchoring device includes a projection that piercingly engages the obstructing member and the air passageway wall.
27. The method of claim 26, wherein the projection is releasable from the air passageway wall for removal of the anchoring device, and the step of removing the anchoring device includes releasing the projection.
28. The method of claim 25, wherein the obstructing member forms a one-way valve.
29. The method of claim 25, wherein a portion of the anchoring device is collapsible.
30. An air passageway obstructing device comprising: obstructing means for obstructing air flow within the air passageway; and anchoring means for anchoring the obstructing means within an air passageway by engaging the obstructing means and the air passageway, and the anchoring means being further releasable for removal of the obstructing means.
PCT/US2003/011974 2002-04-16 2003-04-16 Removable anchored lung volume reduction devices and methods WO2003088912A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2003585665A JP2005523076A (en) 2002-04-16 2003-04-16 Removable anchored lung volume reduction device and method
CA002484086A CA2484086A1 (en) 2002-04-16 2003-04-16 Removable anchored lung volume reduction devices and methods
EP03721749A EP1494657A4 (en) 2002-04-16 2003-04-16 Removable anchored lung volume reduction devices and methods
AU2003225044A AU2003225044B2 (en) 2002-04-16 2003-04-16 Removable anchored lung volume reduction devices and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/124,790 US20030195385A1 (en) 2002-04-16 2002-04-16 Removable anchored lung volume reduction devices and methods
US10/124,790 2002-04-16

Publications (2)

Publication Number Publication Date
WO2003088912A2 true WO2003088912A2 (en) 2003-10-30
WO2003088912A3 WO2003088912A3 (en) 2004-07-22

Family

ID=28790907

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/011974 WO2003088912A2 (en) 2002-04-16 2003-04-16 Removable anchored lung volume reduction devices and methods

Country Status (6)

Country Link
US (3) US20030195385A1 (en)
EP (1) EP1494657A4 (en)
JP (1) JP2005523076A (en)
AU (1) AU2003225044B2 (en)
CA (1) CA2484086A1 (en)
WO (1) WO2003088912A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8251067B2 (en) 2001-03-02 2012-08-28 Pulmonx Corporation Bronchial flow control devices with membrane seal
US9265605B2 (en) 2005-10-14 2016-02-23 Boston Scientific Scimed, Inc. Bronchoscopic lung volume reduction valve

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030050648A1 (en) 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
US6592594B2 (en) * 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
US6929637B2 (en) 2002-02-21 2005-08-16 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US20030181922A1 (en) 2002-03-20 2003-09-25 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US20030216769A1 (en) 2002-05-17 2003-11-20 Dillard David H. Removable anchored lung volume reduction devices and methods
US20030212412A1 (en) * 2002-05-09 2003-11-13 Spiration, Inc. Intra-bronchial obstructing device that permits mucus transport
US7100616B2 (en) 2003-04-08 2006-09-05 Spiration, Inc. Bronchoscopic lung volume reduction method
US7811274B2 (en) 2003-05-07 2010-10-12 Portaero, Inc. Method for treating chronic obstructive pulmonary disease
US7426929B2 (en) 2003-05-20 2008-09-23 Portaero, Inc. Intra/extra-thoracic collateral ventilation bypass system and method
US7252086B2 (en) 2003-06-03 2007-08-07 Cordis Corporation Lung reduction system
US7377278B2 (en) 2003-06-05 2008-05-27 Portaero, Inc. Intra-thoracic collateral ventilation bypass system and method
US7682332B2 (en) 2003-07-15 2010-03-23 Portaero, Inc. Methods to accelerate wound healing in thoracic anastomosis applications
US7533671B2 (en) 2003-08-08 2009-05-19 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
US7775968B2 (en) 2004-06-14 2010-08-17 Pneumrx, Inc. Guided access to lung tissues
US7766891B2 (en) 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
WO2006014567A2 (en) 2004-07-08 2006-02-09 Pneumrx, Inc. Pleural effusion treatment device, method and material
US20060030921A1 (en) * 2004-08-03 2006-02-09 Medtronic Vascular, Inc. Intravascular securement device
WO2006055047A2 (en) 2004-11-18 2006-05-26 Mark Adler Intra-bronchial apparatus for aspiration and insufflation of lung regions distal to placement or cross communication and deployment and placement system therefor
US8220460B2 (en) 2004-11-19 2012-07-17 Portaero, Inc. Evacuation device and method for creating a localized pleurodesis
EP1816945B1 (en) 2004-11-23 2019-08-21 PneumRx, Inc. Steerable device for accessing a target site
US7824366B2 (en) 2004-12-10 2010-11-02 Portaero, Inc. Collateral ventilation device with chest tube/evacuation features and method
US8876791B2 (en) 2005-02-25 2014-11-04 Pulmonx Corporation Collateral pathway treatment using agent entrained by aspiration flow current
US8104474B2 (en) 2005-08-23 2012-01-31 Portaero, Inc. Collateral ventilation bypass system with retention features
US8545530B2 (en) 2005-10-19 2013-10-01 Pulsar Vascular, Inc. Implantable aneurysm closure systems and methods
BRPI0617652A2 (en) 2005-10-19 2011-08-02 Pulsar Vascular Inc methods and systems for endovascular incision and repair of tissue and lumen defects
US7406963B2 (en) 2006-01-17 2008-08-05 Portaero, Inc. Variable resistance pulmonary ventilation bypass valve and method
US8721734B2 (en) 2009-05-18 2014-05-13 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8157837B2 (en) 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US7691151B2 (en) 2006-03-31 2010-04-06 Spiration, Inc. Articulable Anchor
US8617205B2 (en) 2007-02-01 2013-12-31 Cook Medical Technologies Llc Closure device
WO2008094706A2 (en) 2007-02-01 2008-08-07 Cook Incorporated Closure device and method of closing a bodily opening
US8163034B2 (en) 2007-05-11 2012-04-24 Portaero, Inc. Methods and devices to create a chemically and/or mechanically localized pleurodesis
US7931641B2 (en) 2007-05-11 2011-04-26 Portaero, Inc. Visceral pleura ring connector
US8062315B2 (en) 2007-05-17 2011-11-22 Portaero, Inc. Variable parietal/visceral pleural coupling
US8292907B2 (en) * 2007-08-31 2012-10-23 Cook Medical Technologies Llc Balloon assisted occlusion device
US20090062839A1 (en) * 2007-08-31 2009-03-05 Cook Incorporated Barbed stent vascular occlusion device
US8043301B2 (en) 2007-10-12 2011-10-25 Spiration, Inc. Valve loader method, system, and apparatus
US8136230B2 (en) 2007-10-12 2012-03-20 Spiration, Inc. Valve loader method, system, and apparatus
US8475389B2 (en) 2008-02-19 2013-07-02 Portaero, Inc. Methods and devices for assessment of pneumostoma function
US8336540B2 (en) 2008-02-19 2012-12-25 Portaero, Inc. Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease
WO2009105432A2 (en) 2008-02-19 2009-08-27 Portaero, Inc. Devices and methods for delivery of a therapeutic agent through a pneumostoma
US11272979B2 (en) 2008-04-29 2022-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US11254926B2 (en) 2008-04-29 2022-02-22 Virginia Tech Intellectual Properties, Inc. Devices and methods for high frequency electroporation
US9598691B2 (en) 2008-04-29 2017-03-21 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation to create tissue scaffolds
US10245098B2 (en) 2008-04-29 2019-04-02 Virginia Tech Intellectual Properties, Inc. Acute blood-brain barrier disruption using electrical energy based therapy
US9198733B2 (en) 2008-04-29 2015-12-01 Virginia Tech Intellectual Properties, Inc. Treatment planning for electroporation-based therapies
US10117707B2 (en) 2008-04-29 2018-11-06 Virginia Tech Intellectual Properties, Inc. System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies
US9283051B2 (en) 2008-04-29 2016-03-15 Virginia Tech Intellectual Properties, Inc. System and method for estimating a treatment volume for administering electrical-energy based therapies
US10238447B2 (en) 2008-04-29 2019-03-26 Virginia Tech Intellectual Properties, Inc. System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress
US9867652B2 (en) 2008-04-29 2018-01-16 Virginia Tech Intellectual Properties, Inc. Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds
US10272178B2 (en) 2008-04-29 2019-04-30 Virginia Tech Intellectual Properties Inc. Methods for blood-brain barrier disruption using electrical energy
US10702326B2 (en) 2011-07-15 2020-07-07 Virginia Tech Intellectual Properties, Inc. Device and method for electroporation based treatment of stenosis of a tubular body part
US10448989B2 (en) 2009-04-09 2019-10-22 Virginia Tech Intellectual Properties, Inc. High-frequency electroporation for cancer therapy
US8992517B2 (en) 2008-04-29 2015-03-31 Virginia Tech Intellectual Properties Inc. Irreversible electroporation to treat aberrant cell masses
ES2879278T3 (en) 2008-09-05 2021-11-22 Pulsar Vascular Inc Systems to support or occlude a physiological opening or cavity
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US8347881B2 (en) 2009-01-08 2013-01-08 Portaero, Inc. Pneumostoma management device with integrated patency sensor and method
US8518053B2 (en) 2009-02-11 2013-08-27 Portaero, Inc. Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease
US11638603B2 (en) 2009-04-09 2023-05-02 Virginia Tech Intellectual Properties, Inc. Selective modulation of intracellular effects of cells using pulsed electric fields
US11382681B2 (en) 2009-04-09 2022-07-12 Virginia Tech Intellectual Properties, Inc. Device and methods for delivery of high frequency electrical pulses for non-thermal ablation
US8903488B2 (en) 2009-05-28 2014-12-02 Angiodynamics, Inc. System and method for synchronizing energy delivery to the cardiac rhythm
US9895189B2 (en) 2009-06-19 2018-02-20 Angiodynamics, Inc. Methods of sterilization and treating infection using irreversible electroporation
JP5731512B2 (en) 2009-09-04 2015-06-10 パルサー バスキュラー インコーポレイテッド System and method for sealing an anatomical opening
US8425455B2 (en) 2010-03-30 2013-04-23 Angiodynamics, Inc. Bronchial catheter and method of use
WO2012051489A2 (en) 2010-10-15 2012-04-19 Cook Medical Technologies Llc Occlusion device for blocking fluid flow through bodily passages
US8795241B2 (en) 2011-05-13 2014-08-05 Spiration, Inc. Deployment catheter
ES2656328T3 (en) 2011-06-03 2018-02-26 Pulsar Vascular, Inc. Aneurism devices with additional anchoring mechanisms and associated systems
US10004510B2 (en) 2011-06-03 2018-06-26 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices
US9078665B2 (en) 2011-09-28 2015-07-14 Angiodynamics, Inc. Multiple treatment zone ablation probe
EP3735916A1 (en) 2011-10-05 2020-11-11 Pulsar Vascular, Inc. Devices for enclosing an anatomical opening
WO2013120082A1 (en) 2012-02-10 2013-08-15 Kassab Ghassan S Methods and uses of biological tissues for various stent and other medical applications
WO2013130484A1 (en) * 2012-02-28 2013-09-06 Spiration, Inc. Pulmonary nodule access devices and methods of using the same
US9259229B2 (en) 2012-05-10 2016-02-16 Pulsar Vascular, Inc. Systems and methods for enclosing an anatomical opening, including coil-tipped aneurysm devices
AU2014214700B2 (en) 2013-02-11 2018-01-18 Cook Medical Technologies Llc Expandable support frame and medical device
WO2015143357A2 (en) 2014-03-21 2015-09-24 Boston Scientific Scimed, Inc. Devices and methods for treating a lung
JP6594901B2 (en) 2014-05-12 2019-10-23 バージニア テック インテレクチュアル プロパティース インコーポレイテッド Selective modulation of intracellular effects of cells using pulsed electric fields
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
WO2016100325A1 (en) 2014-12-15 2016-06-23 Virginia Tech Intellectual Properties, Inc. Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment
WO2016115193A1 (en) * 2015-01-14 2016-07-21 Shifamed Holdings, Llc Devices and methods for lung volume reduction
GB2550099B (en) * 2015-03-24 2020-09-02 Gyrus Acmi Inc Airway stent
CN104707192A (en) * 2015-04-07 2015-06-17 周韶辉 Reverse treatment device for pulmonary bullae
JP6695443B2 (en) * 2016-03-30 2020-05-20 スパイレーション インコーポレイテッド ディー ビー エイ オリンパス レスピラトリー アメリカ Airway valve including anchor
US10905492B2 (en) 2016-11-17 2021-02-02 Angiodynamics, Inc. Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode
US11607537B2 (en) 2017-12-05 2023-03-21 Virginia Tech Intellectual Properties, Inc. Method for treating neurological disorders, including tumors, with electroporation
WO2019126683A1 (en) * 2017-12-22 2019-06-27 Free Flow Medical, Inc. Devices, treatments and methods to restore tissue elastic recoil
US11311329B2 (en) 2018-03-13 2022-04-26 Virginia Tech Intellectual Properties, Inc. Treatment planning for immunotherapy based treatments using non-thermal ablation techniques
US11925405B2 (en) 2018-03-13 2024-03-12 Virginia Tech Intellectual Properties, Inc. Treatment planning system for immunotherapy enhancement via non-thermal ablation
WO2020023365A1 (en) * 2018-07-23 2020-01-30 Eolo Medical Inc. Methods and devices for the treatment of pulmonary disorders with implantable valves
CN110742667A (en) * 2018-07-23 2020-02-04 苏州优友瑞医疗科技有限公司 Methods and devices for treating pulmonary dysfunction using implantable valves

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174323B1 (en) * 1998-06-05 2001-01-16 Broncus Technologies, Inc. Method and assembly for lung volume reduction

Family Cites Families (136)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981254A (en) * 1957-11-12 1961-04-25 Edwin G Vanderbilt Apparatus for the gas deflation of an animal's stomach
US3540431A (en) * 1968-04-04 1970-11-17 Kazi Mobin Uddin Collapsible filter for fluid flowing in closed passageway
US3657744A (en) * 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US3788327A (en) * 1971-03-30 1974-01-29 H Donowitz Surgical implant device
US3874388A (en) * 1973-02-12 1975-04-01 Ochsner Med Found Alton Shunt defect closure system
US4014318A (en) * 1973-08-20 1977-03-29 Dockum James M Circulatory assist device and system
US4086665A (en) * 1976-12-16 1978-05-02 Thermo Electron Corporation Artificial blood conduit
US4250873A (en) * 1977-04-26 1981-02-17 Richard Wolf Gmbh Endoscopes
US4212463A (en) * 1978-02-17 1980-07-15 Pratt Enoch B Humane bleeder arrow
DE3019996A1 (en) * 1980-05-24 1981-12-03 Institute für Textil- und Faserforschung Stuttgart, 7410 Reutlingen HOHLORGAN
US4808183A (en) * 1980-06-03 1989-02-28 University Of Iowa Research Foundation Voice button prosthesis and method for installing same
US4302854A (en) * 1980-06-04 1981-12-01 Runge Thomas M Electrically activated ferromagnetic/diamagnetic vascular shunt for left ventricular assist
US4727873A (en) * 1984-04-17 1988-03-01 Mobin Uddin Kazi Embolus trap
DK151404C (en) * 1984-05-23 1988-07-18 Cook Europ Aps William FULLY FILTER FOR IMPLANTATION IN A PATIENT'S BLOOD
DE3583141D1 (en) * 1984-11-15 1991-07-11 Stefano Nazari DEVICE FOR SELECTIVE BRONCHIAL INTUBATION AND SEPARATE LUNG VENTILATION.
IT1186142B (en) * 1984-12-05 1987-11-18 Medinvent Sa TRANSLUMINAL IMPLANTATION DEVICE
US4759758A (en) * 1984-12-07 1988-07-26 Shlomo Gabbay Prosthetic heart valve
US4681110A (en) * 1985-12-02 1987-07-21 Wiktor Dominik M Catheter arrangement having a blood vessel liner, and method of using it
US4710192A (en) * 1985-12-30 1987-12-01 Liotta Domingo S Diaphragm and method for occlusion of the descending thoracic aorta
US4832680A (en) * 1986-07-03 1989-05-23 C.R. Bard, Inc. Apparatus for hypodermically implanting a genitourinary prosthesis
US4795449A (en) * 1986-08-04 1989-01-03 Hollister Incorporated Female urinary incontinence device
US4852568A (en) * 1987-02-17 1989-08-01 Kensey Nash Corporation Method and apparatus for sealing an opening in tissue of a living being
DE3821631A1 (en) * 1987-07-28 1989-02-09 Bader Paul CLOSURE FOR A MALE UTILITY
US4830003A (en) * 1988-06-17 1989-05-16 Wolff Rodney G Compressive stent and delivery system
JP2710355B2 (en) * 1988-09-20 1998-02-10 日本ゼオン株式会社 Medical valve device
US4846836A (en) * 1988-10-03 1989-07-11 Reich Jonathan D Artificial lower gastrointestinal valve
US4877025A (en) * 1988-10-06 1989-10-31 Hanson Donald W Tracheostomy tube valve apparatus
DE3834545A1 (en) * 1988-10-11 1990-04-12 Rau Guenter FLEXIBLE LOCKING ORGAN, PARTICULARLY HEART VALVE, AND METHOD FOR PRODUCING THE SAME
US4968294A (en) * 1989-02-09 1990-11-06 Salama Fouad A Urinary control valve and method of using same
US5800339A (en) * 1989-02-09 1998-09-01 Opticon Medical Inc. Urinary control valve
DK0474748T3 (en) * 1989-05-31 1995-05-01 Baxter Int Biological flap prosthesis
US5352240A (en) * 1989-05-31 1994-10-04 Promedica International, Inc. Human heart valve replacement with porcine pulmonary valve
US5314473A (en) * 1989-07-20 1994-05-24 Godin Norman J Prosthesis for preventing gastric reflux into the esophagus
US5562608A (en) * 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US5061274A (en) * 1989-12-04 1991-10-29 Kensey Nash Corporation Plug device for sealing openings and method of use
DK124690D0 (en) * 1990-05-18 1990-05-18 Henning Rud Andersen FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION
US5411552A (en) * 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5116360A (en) * 1990-12-27 1992-05-26 Corvita Corporation Mesh composite graft
IT1247037B (en) * 1991-06-25 1994-12-12 Sante Camilli ARTIFICIAL VENOUS VALVE
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US5151105A (en) * 1991-10-07 1992-09-29 Kwan Gett Clifford Collapsible vessel sleeve implant
US5662713A (en) * 1991-10-09 1997-09-02 Boston Scientific Corporation Medical stents for body lumens exhibiting peristaltic motion
US5123919A (en) * 1991-11-21 1992-06-23 Carbomedics, Inc. Combined prosthetic aortic heart valve and vascular graft
IT1253903B (en) * 1991-12-05 1995-08-31 Luigi Gigante VALVE CATHETER FOR INCONTINENCE AND URINARY RETENTION
JP3393383B2 (en) * 1992-01-21 2003-04-07 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ Septal defect closure device
US5283063A (en) * 1992-01-31 1994-02-01 Eagle Vision Punctum plug method and apparatus
US5509900A (en) * 1992-03-02 1996-04-23 Kirkman; Thomas R. Apparatus and method for retaining a catheter in a blood vessel in a fixed position
US5409444A (en) * 1992-03-04 1995-04-25 Kensey Nash Corporation Method and apparatus to reduce injury to the vascular system
US5382261A (en) * 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5409019A (en) * 1992-10-30 1995-04-25 Wilk; Peter J. Coronary artery by-pass method
US5304199A (en) * 1993-01-04 1994-04-19 Gene E. Myers Enterprises, Inc. Apparatus for arterial total occlusion plaque separation
DE4300285A1 (en) * 1993-01-08 1994-07-14 Wolf Gmbh Richard Instrument for implanting and extracting stents
US5797960A (en) * 1993-02-22 1998-08-25 Stevens; John H. Method and apparatus for thoracoscopic intracardiac procedures
US5306234A (en) * 1993-03-23 1994-04-26 Johnson W Dudley Method for closing an atrial appendage
WO1994023786A1 (en) * 1993-04-13 1994-10-27 Boston Scientific Corporation Prosthesis delivery system
US5486154A (en) * 1993-06-08 1996-01-23 Kelleher; Brian S. Endoscope
US5366478A (en) * 1993-07-27 1994-11-22 Ethicon, Inc. Endoscopic surgical sealing device
US5542594A (en) * 1993-10-06 1996-08-06 United States Surgical Corporation Surgical stapling apparatus with biocompatible surgical fabric
US5503638A (en) * 1994-02-10 1996-04-02 Bio-Vascular, Inc. Soft tissue stapling buttress
US5392775A (en) * 1994-03-22 1995-02-28 Adkins, Jr.; Claude N. Duckbill valve for a tracheostomy tube that permits speech
US5499995C1 (en) * 1994-05-25 2002-03-12 Paul S Teirstein Body passageway closure apparatus and method of use
US5683451A (en) * 1994-06-08 1997-11-04 Cardiovascular Concepts, Inc. Apparatus and methods for deployment release of intraluminal prostheses
US5417226A (en) * 1994-06-09 1995-05-23 Juma; Saad Female anti-incontinence device
US5549626A (en) * 1994-12-23 1996-08-27 New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery Vena caval filter
US5755770A (en) * 1995-01-31 1998-05-26 Boston Scientific Corporatiion Endovascular aortic graft
US5676671A (en) * 1995-04-12 1997-10-14 Inoue; Kanji Device for introducing an appliance to be implanted into a catheter
US5725965A (en) * 1995-04-25 1998-03-10 Gas Research Institute Stable high conductivity functionally gradient compositionally layered solid state electrolytes and membranes
US5704910A (en) * 1995-06-05 1998-01-06 Nephros Therapeutics, Inc. Implantable device and use therefor
US5645565A (en) * 1995-06-13 1997-07-08 Ethicon Endo-Surgery, Inc. Surgical plug
US5702409A (en) * 1995-07-21 1997-12-30 W. L. Gore & Associates, Inc. Device and method for reinforcing surgical staples
US5697968A (en) * 1995-08-10 1997-12-16 Aeroquip Corporation Check valve for intraluminal graft
US5660175A (en) * 1995-08-21 1997-08-26 Dayal; Bimal Endotracheal device
EP0955933B1 (en) * 1995-10-13 2009-08-26 Medtronic Vascular, Inc. A device for interstitial transvascular intervention
JP3690815B2 (en) * 1996-05-20 2005-08-31 メドトロニック パークサージ インコーポレイテッド Small section catheter
EP0808614B1 (en) * 1996-05-23 2003-02-26 Samsung Electronics Co., Ltd. Flexible self-expandable stent and method for making the same
KR980000327U (en) * 1996-06-13 1998-03-30 이정행 Earring hole molding for earring installation
US5855601A (en) * 1996-06-21 1999-01-05 The Trustees Of Columbia University In The City Of New York Artificial heart valve and method and device for implanting the same
US5782916A (en) * 1996-08-13 1998-07-21 Galt Laboratories, Inc. Device for maintaining urinary continence
US5725519A (en) * 1996-09-30 1998-03-10 Medtronic Instent Israel Ltd. Stent loading device for a balloon catheter
US5752965A (en) * 1996-10-21 1998-05-19 Bio-Vascular, Inc. Apparatus and method for producing a reinforced surgical fastener suture line
US6447530B1 (en) * 1996-11-27 2002-09-10 Scimed Life Systems, Inc. Atraumatic anchoring and disengagement mechanism for permanent implant device
NL1004827C2 (en) * 1996-12-18 1998-06-19 Surgical Innovations Vof Device for regulating blood circulation.
EP0850607A1 (en) * 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
US5851232A (en) * 1997-03-15 1998-12-22 Lois; William A. Venous stent
US6059812A (en) * 1997-03-21 2000-05-09 Schneider (Usa) Inc. Self-expanding medical device for centering radioactive treatment sources in body vessels
US6083255A (en) * 1997-04-07 2000-07-04 Broncus Technologies, Inc. Bronchial stenter
US6488673B1 (en) * 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US6200333B1 (en) * 1997-04-07 2001-03-13 Broncus Technologies, Inc. Bronchial stenter
GB2324729B (en) * 1997-04-30 2002-01-02 Bradford Hospitals Nhs Trust Lung treatment device
US5855597A (en) * 1997-05-07 1999-01-05 Iowa-India Investments Co. Limited Stent valve and stent graft for percutaneous surgery
US6245102B1 (en) * 1997-05-07 2001-06-12 Iowa-India Investments Company Ltd. Stent, stent graft and stent valve
US6010525A (en) * 1997-08-01 2000-01-04 Peter M. Bonutti Method and apparatus for securing a suture
US5954766A (en) * 1997-09-16 1999-09-21 Zadno-Azizi; Gholam-Reza Body fluid flow control device
US5925063A (en) * 1997-09-26 1999-07-20 Khosravi; Farhad Coiled sheet valve, filter or occlusive device and methods of use
CA2308426A1 (en) * 1997-11-03 1999-05-14 William A. Easterbrook, Iii Method and apparatus for assisting a heart to pump blood
US6254642B1 (en) * 1997-12-09 2001-07-03 Thomas V. Taylor Perorally insertable gastroesophageal anti-reflux valve prosthesis and tool for implantation thereof
EP0941713B1 (en) * 1998-03-04 2004-11-03 Schneider (Europe) GmbH Device to insert an endoprosthesis into a catheter shaft
US6009614A (en) * 1998-04-21 2000-01-04 Advanced Cardiovascular Systems, Inc. Stent crimping tool and method of use
US5974652A (en) * 1998-05-05 1999-11-02 Advanced Cardiovascular Systems, Inc. Method and apparatus for uniformly crimping a stent onto a catheter
US6264700B1 (en) * 1998-08-27 2001-07-24 Endonetics, Inc. Prosthetic gastroesophageal valve
US6020380A (en) * 1998-11-25 2000-02-01 Tap Holdings Inc. Method of treating chronic obstructive pulmonary disease
US6051022A (en) * 1998-12-30 2000-04-18 St. Jude Medical, Inc. Bileaflet valve having non-parallel pivot axes
EP1025874B1 (en) * 1999-02-01 2003-08-27 Adeva Medical Gesellschaft für Entwicklung und Vertrieb von Medizinischen Implantat-Artikeln mbH Tracheostomy valve
US6425916B1 (en) * 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US6206918B1 (en) * 1999-05-12 2001-03-27 Sulzer Carbomedics Inc. Heart valve prosthesis having a pivot design for improving flow characteristics
US6234996B1 (en) * 1999-06-23 2001-05-22 Percusurge, Inc. Integrated inflation/deflation device and method
US6287290B1 (en) * 1999-07-02 2001-09-11 Pulmonx Methods, systems, and kits for lung volume reduction
EP1143864B1 (en) * 1999-08-05 2004-02-04 Broncus Technologies, Inc. Methods and devices for creating collateral channels in the lungs
US6712812B2 (en) * 1999-08-05 2004-03-30 Broncus Technologies, Inc. Devices for creating collateral channels
US6610043B1 (en) * 1999-08-23 2003-08-26 Bistech, Inc. Tissue volume reduction
US6293951B1 (en) * 1999-08-24 2001-09-25 Spiration, Inc. Lung reduction device, system, and method
US6328689B1 (en) * 2000-03-23 2001-12-11 Spiration, Inc., Lung constriction apparatus and method
US6416554B1 (en) * 1999-08-24 2002-07-09 Spiration, Inc. Lung reduction apparatus and method
US6402754B1 (en) * 1999-10-20 2002-06-11 Spiration, Inc. Apparatus for expanding the thorax
US6398775B1 (en) * 1999-10-21 2002-06-04 Pulmonx Apparatus and method for isolated lung access
US6510846B1 (en) * 1999-12-23 2003-01-28 O'rourke Sam Sealed back pressure breathing device
US6679264B1 (en) * 2000-03-04 2004-01-20 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US6514290B1 (en) * 2000-03-31 2003-02-04 Broncus Technologies, Inc. Lung elastic recoil restoring or tissue compressing device and method
US6568387B2 (en) * 2000-07-19 2003-05-27 University Of Florida Method for treating chronic obstructive pulmonary disorder
US20020147462A1 (en) * 2000-09-11 2002-10-10 Closure Medical Corporation Bronchial occlusion method and apparatus
US6585639B1 (en) * 2000-10-27 2003-07-01 Pulmonx Sheath and method for reconfiguring lung viewing scope
US6527761B1 (en) * 2000-10-27 2003-03-04 Pulmonx, Inc. Methods and devices for obstructing and aspirating lung tissue segments
US20020112729A1 (en) * 2001-02-21 2002-08-22 Spiration, Inc. Intra-bronchial obstructing device that controls biological interaction with the patient
US6860847B2 (en) * 2001-07-10 2005-03-01 Spiration, Inc. Constriction device viewable under X ray fluoroscopy
JP4602602B2 (en) * 2001-07-19 2010-12-22 オリンパス株式会社 Medical instruments
US20030018327A1 (en) * 2001-07-20 2003-01-23 Csaba Truckai Systems and techniques for lung volume reduction
US6743259B2 (en) * 2001-08-03 2004-06-01 Core Medical, Inc. Lung assist apparatus and methods for use
EP1435833B1 (en) * 2001-09-10 2014-05-21 Pulmonx Apparatus for endobronchial diagnosis
US20030050648A1 (en) * 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
WO2003022134A2 (en) * 2001-09-11 2003-03-20 Pulmonx Methods of endobronchial diagnosis using imaging
EP1434615B1 (en) * 2001-10-11 2007-07-11 Emphasys Medical, Inc. Bronchial flow control device
US6592594B2 (en) * 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
US20030127090A1 (en) * 2001-11-14 2003-07-10 Emphasys Medical, Inc. Active pump bronchial implant devices and methods of use thereof
US6929637B2 (en) * 2002-02-21 2005-08-16 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US20030154988A1 (en) * 2002-02-21 2003-08-21 Spiration, Inc. Intra-bronchial device that provides a medicant intra-bronchially to the patient
US20040039250A1 (en) * 2002-05-28 2004-02-26 David Tholfsen Guidewire delivery of implantable bronchial isolation devices in accordance with lung treatment

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174323B1 (en) * 1998-06-05 2001-01-16 Broncus Technologies, Inc. Method and assembly for lung volume reduction

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1494657A2 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8251067B2 (en) 2001-03-02 2012-08-28 Pulmonx Corporation Bronchial flow control devices with membrane seal
US9265605B2 (en) 2005-10-14 2016-02-23 Boston Scientific Scimed, Inc. Bronchoscopic lung volume reduction valve

Also Published As

Publication number Publication date
AU2003225044B2 (en) 2007-12-13
US20060235467A1 (en) 2006-10-19
US20030195385A1 (en) 2003-10-16
US20080015627A1 (en) 2008-01-17
EP1494657A4 (en) 2009-02-18
CA2484086A1 (en) 2003-10-30
EP1494657A2 (en) 2005-01-12
WO2003088912A3 (en) 2004-07-22
JP2005523076A (en) 2005-08-04
AU2003225044A1 (en) 2003-11-03
AU2003225044A2 (en) 2003-11-03

Similar Documents

Publication Publication Date Title
AU2003225044B2 (en) Removable anchored lung volume reduction devices and methods
US9358013B2 (en) One-way valve devices for anchored implantation in a lung
US8926647B2 (en) Removable anchored lung volume reduction devices and methods
US8414655B2 (en) Removable lung reduction devices, systems, and methods
US20020112729A1 (en) Intra-bronchial obstructing device that controls biological interaction with the patient
EP2353557B1 (en) Removable anchored lung volume reduction devices

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2484086

Country of ref document: CA

Ref document number: 2003585665

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2003721749

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003225044

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2003721749

Country of ref document: EP